347
Participants
Start Date
March 31, 2016
Primary Completion Date
November 30, 2018
Study Completion Date
May 31, 2019
PPV-23
PPV-23 was a polysaccharide PNC vaccine, licensed in Brazil, directed against 23 serotypes.
PCV-10
PCV-10 was a conjugate PNC vaccine, licensed in Brazil, directed against 10 serotypes.
NaCl
NaCl was the placebo for the study against which the two vaccines were compared during pregnancy.
FUNDEP (Belo Horizonte), Belo Horizonte
Hospital Geral de Nova Iguaçu Avenida Henrique Duque Estrada Mayer, Nova Iguaçu
Instituto de Puericultura e Pediatria Martagao Gesteria, Rio de Janeiro
Hospital dos Servidores (Rio de Janeiro), Saúde
Universidade de Caxias do Sul. Brasil, Caxias do Sul
Hospital Santa Casa Porto Alegre Brazil, Porto Alegre
Hospital Nossa Senhora da Conceicao, Porto Alegre
Ribeirão Preto Medical School, University of São Paulo, Brazil, Ribeirão Preto
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Westat
OTHER